NatWest Group plc Lowers Position in Lam Research Corporation $LRCX

NatWest Group plc trimmed its stake in shares of Lam Research Corporation (NASDAQ:LRCX) by 12.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 83,385 shares of the semiconductor company’s stock after selling 11,440 shares during the period. Lam Research accounts for 3.3% of NatWest Group plc’s portfolio, making the stock its 11th largest holding. NatWest Group plc’s holdings in Lam Research were worth $14,274,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. PMV Capital Advisers LLC purchased a new stake in Lam Research in the 4th quarter worth $25,000. Stance Capital LLC purchased a new position in shares of Lam Research during the third quarter valued at about $26,000. Howard Hughes Medical Institute bought a new stake in shares of Lam Research in the second quarter worth about $27,000. Triumph Capital Management purchased a new stake in shares of Lam Research in the third quarter worth about $27,000. Finally, Strategic Wealth Investment Group LLC purchased a new stake in shares of Lam Research in the second quarter worth about $29,000. 84.61% of the stock is currently owned by institutional investors.

Insider Activity

In other news, insider Ava Harter sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total value of $333,990.00. Following the completion of the sale, the insider owned 53,205 shares in the company, valued at approximately $11,846,625.30. This trade represents a 2.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Douglas R. Bettinger sold 50,057 shares of Lam Research stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the transaction, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at approximately $242,334,371.15. This represents a 4.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is currently owned by company insiders.

Lam Research Price Performance

NASDAQ:LRCX opened at $211.62 on Friday. The firm has a market capitalization of $264.26 billion, a price-to-earnings ratio of 43.36, a PEG ratio of 2.51 and a beta of 1.77. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $256.68. The business has a 50 day simple moving average of $228.05 and a 200-day simple moving average of $180.61. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm had revenue of $5.34 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the company posted $0.91 EPS. The company’s revenue for the quarter was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.5%. Lam Research’s payout ratio is 21.31%.

Analysts Set New Price Targets

Several equities analysts have weighed in on LRCX shares. The Goldman Sachs Group set a $262.00 price target on Lam Research and gave the company a “buy” rating in a report on Thursday, January 29th. Barclays upped their price objective on Lam Research from $250.00 to $255.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 10th. Summit Insights upgraded Lam Research from a “hold” rating to a “buy” rating in a research report on Thursday, January 29th. Susquehanna set a $325.00 price target on shares of Lam Research and gave the stock a “positive” rating in a research report on Thursday, January 29th. Finally, Argus upped their price target on shares of Lam Research from $175.00 to $280.00 in a research note on Tuesday, February 3rd. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $245.35.

Trending Headlines about Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Erste Group slightly raised its FY2027 EPS estimate for Lam (from $7.00 to $7.02), signaling continued analyst confidence in Lam’s longer‑term profitability. Read More.
• Positive Sentiment: Bullish research pieces argue Lam is positioned for continued growth due to rising chip process complexity and AI-driven capital expenditures — supportive for medium/long-term revenue and margins. Read More.
• Positive Sentiment: Investment letters and coverage (e.g., Renaissance in a large‑cap growth strategy) highlight Lam’s exposure to growing chip complexity, a structural tailwind for deposition/etch equipment. Read More.
• Positive Sentiment: Technical/flow-driven buying signals have supported the stock recently (not fundamental-driven), which can amplify short-term rallies. Read More.
• Neutral Sentiment: Industry note: Applied Materials stands to benefit from rising HBM and advanced packaging demand — an industry tailwind that should also help Lam over time, though AMAT‑specific coverage may not translate directly into immediate upside for LRCX. Read More.
• Neutral Sentiment: Valuation write‑ups ask whether recent multi‑year gains already price in Lam’s growth; useful for timing entries but not a near‑term catalyst. Read More.
• Negative Sentiment: Immediate negative: investors sold LRCX after news that Google’s TurboQuant can significantly reduce memory requirements for AI models. That development raises short‑term uncertainty around demand for HBM and packaging — key end markets for advanced wafer‑fab equipment. This appears to be the primary driver of today’s pullback. Read More.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.